FAM
MRK icon

Fairtree Asset Management’s Merck MRK Stock Holding History

Fairtree Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,842
Closed -$910K – 115
2025
Q3 		$910K Sell
10,842
-3,184
-23% -$262K 0.6% 57
2025
Q2 		$1.11M Buy
14,026
+6,015
+75% +$478K 0.84% 30
2025
Q1 		$719K Buy
+8,011
New +$748K 0.58% 45

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fairtree Asset Management's MRK Position: Q4 2025 in Review

Fairtree Asset Management sold out of Merck (MRK) in Q4 2025, closing a stake of 10,842 shares — an estimated $910K sold.

Fairtree Asset Management first reported a position in MRK in Q1 2025 and held it in 3 quarters. The position peaked at $1.11M in Q2 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Fairtree Asset Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Fairtree Asset Management sold 10,842 Merck shares in Q4 2025, an estimated $910K.
  • Fairtree Asset Management first reported a position in Merck in Q1 2025 and held it in 3 quarters.
  • Fairtree Asset Management's Merck position peaked at $1.11M in Q2 2025.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Fairtree Asset Management's 13F filing for Q4 2025, filed 6 Feb 2026.